Physician profile
Barney E Blue
NPI 1205807773
$1,648.39
in general payments reported to CMS, 2019-2025
25 companies · $63.46 in 2025
The $63.46 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $359 · 2021: $509 · 2022: $204 · 2023: $71.25 · 2024: $135 · 2025: $63.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $440.53 | 2019-2025 | |
| Astellas Pharma US INC | $350.92 | 2019-2024 | Veozah |
| Abbvie INC. | $118.39 | 2021-2023 | Vraylar |
| Novo Nordisk INC | $105.07 | 2019-2021 | |
| Amgen INC. | $89.54 | 2022-2023 | Repatha, Otezla |
| Lilly USA, LLC | $73.86 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $50.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.39 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $39.74 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $35.62 | 2022 | |
| Exact Sciences Corporation | $33.18 | 2024-2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $32.93 | 2021 | |
| Baxter Healthcare | $26.85 | 2025 | Hillrom - Monarch Airway Clearance System |
| Dexcom, INC. | $25.70 | 2022 | |
| Bausch & Lomb Americas INC. | $21.63 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.42 | 2024 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.70 | 2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $18.42 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.24 | 2024 | |
| Allergan, INC. | $16.83 | 2020 | |
| Genentech USA, INC. | $15.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.94 | 2020 | |
| Ironshore Pharmaceuticals INC. | $14.87 | 2019 | |
| Horizon Therapeutics Plc | $14.45 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barney Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.